Virsti Therapeutics
Stanford, US · Founded 2021 · Delaware corporation
Find your way into Virsti Therapeutics
Sign up to see every warm intro you have to Virsti Therapeutics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Virsti Therapeutics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
AE
Allen Ebens, Ph.D.Executive
JC
Jennifer Cochran, Ph.D.Named on SEC filing
Board
HL
Heath Lukatch, Ph.D.Board director
JE
Jon Edwards, Ph.D.Board director
Reported raises · per SEC filings
Form D private placements$1.4M disclosed across 1 round · 2021
▶$1.4MraisedApr 2021 · 1 investors · PharmaceuticalsRule 506(b)
▶$1.4MraisedApr 2021 · 1 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Heath Lukatch, Ph.D.Director
- Jennifer Cochran, Ph.D.Director
- Jon Edwards, Ph.D.Director
- Allen Ebens, Ph.D.Executive Officer, Director
- Offering amount
- $3M
- Amount sold
- $1.4M
- First sale
- Apr 2021
- Incorporated
- Corporation, Delaware, 2021
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Virsti Therapeutics raised?
- Virsti Therapeutics has disclosed $1.4M raised across 1 round.
- Where is Virsti Therapeutics headquartered?
- Virsti Therapeutics is headquartered in Stanford, US.